Longboard Pharmaceuticals, Inc. (LBPH)

Dec 2, 2024 - LBPH was delisted (reason: acquired by Lundbeck)

59.98

0.00 (0.00%)

Inactive · Last trade price on Nov 29, 2024

Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	27.61	14.33	10.78	66.35	55.32
Short-Term Investments	260.84	34.17	56.81	40.38	-
Cash & Short-Term Investments	288.45	48.5	67.59	106.73	55.32
Cash Growth	414.94%	-28.25%	-36.67%	92.94%	-
Prepaid Expenses	4.58	1.72	2.25	1.66	0.05
Total Current Assets	293.03	50.22	69.84	108.38	55.36
Property, Plant & Equipment	3.73	0.48	0.75	0.54	-
Long-Term Deferred Charges	-	-	-	-	0.88
Other Long-Term Assets	0.24	-	0.03	0.03	-
Total Assets	297.01	50.7	70.62	108.95	56.24

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Accounts Payable	1.13	1	1.31	1.03	1.21
Accrued Expenses	16.92	8.26	7.06	3.91	1.92
Current Portion of Leases	0.27	0.48	0.36	0.34	-
Current Income Taxes Payable	0.03	0.04	0.03	0.17	-
Total Current Liabilities	18.35	9.77	8.76	5.44	3.14
Long-Term Leases	3.47	-	0.38	0.19	-
Total Liabilities	21.82	9.77	9.15	5.63	3.14

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Common Stock	0	0	0	0	-
Additional Paid-In Capital	476.36	181.56	148.3	145.68	11.71
Retained Earnings	-201.88	-140.56	-86.14	-42.2	-14.4
Comprehensive Income & Other	0.7	-0.08	-0.69	-0.16	-
Total Common Equity	275.19	40.92	61.47	103.32	-2.69
Shareholders' Equity	275.19	40.92	61.47	103.32	53.1
Total Liabilities & Equity	297.01	50.7	70.62	108.95	56.24

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Debt	3.73	0.48	0.74	0.52	-
Net Cash (Debt)	284.71	48.02	66.85	106.2	55.32
Net Cash Growth	412.87%	-28.16%	-37.05%	91.99%	-
Net Cash Per Share	8.30	2.11	3.90	7.37	14.52
Filing Date Shares Outstanding	39.05	36.02	22.97	17.22	3.84
Total Common Shares Outstanding	39.03	24.52	17.22	17.22	3.84
Working Capital	274.68	40.45	61.07	102.94	52.23
Book Value Per Share	7.05	1.67	3.57	6.00	-0.70
Tangible Book Value	275.19	40.92	61.47	103.32	-2.69
Tangible Book Value Per Share	7.05	1.67	3.57	6.00	-0.70

SEC Filings: 10-K · 10-Q